Lilly, others pump VC into biotech firm-WEB ONLY
Eli Lilly and Co. has joined three of its fiercest rivals to invest $40 million in a Massachusetts-based biotech company with potentially breakthrough drug technology. Aileron Therapeutics announced the funding Monday from Indianapolis-based Lilly, as well as Novartis AG and Roche Holding AG, both based in Switzerland, and GlaxoSmithKline PLC, based in the United Kingdom. […]